INS and kidney disorder: STZ is the most commonly used agent for inducing type 1 DM because it can trigger specific necrosis of β islets of pancreatic cells that causes degranulation and reduces their ability to discharge insulin, thus, instigating hyperglycemia and nephropathy (Bidani et al., 2007).